Dusigitumab
id:
dusigitumab-319-17106937
title:
Dusigitumab
text:
Dusigitumab is a human monoclonal antibody designed for the treatment of cancer. It binds to IGF2. It was developed by MedImmune, which was acquired by AstraZeneca, using Xenomouse technology licensed from Abgenix. Its development has been discontinued.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dusigitumab
date created:
date modified:
2023-12-20T19:21:45Z
main entity:
{"identifier":"Q5316908","url":"https://www.wikidata.org/entity/Q5316908"}
image:
fields total:
13
integrity:
14